Olle Vikrot

884 total citations
37 papers, 762 citations indexed

About

Olle Vikrot is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Olle Vikrot has authored 37 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Nutrition and Dietetics. Recurrent topics in Olle Vikrot's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Fatty Acid Research and Health (6 papers) and Renal function and acid-base balance (5 papers). Olle Vikrot is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Fatty Acid Research and Health (6 papers) and Renal function and acid-base balance (5 papers). Olle Vikrot collaborates with scholars based in Sweden, United Kingdom and Norway. Olle Vikrot's co-authors include Lars Wallentin, Alvar Svanborg, Ann‐Marie Hôgdahl, Ulf Larsson‐Cohn, Ragnar Berlin, Leif Hallberg, Ola Nilsson, Olav Axelson, Sam Brody and Ulf Flodin and has published in prestigious journals such as The Lancet, Journal of Internal Medicine and European Journal of Endocrinology.

In The Last Decade

Olle Vikrot

36 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olle Vikrot Sweden 16 265 239 148 123 95 37 762
D Mendelsohn South Africa 15 165 0.6× 349 1.5× 109 0.7× 133 1.1× 55 0.6× 50 664
S. Martini Italy 14 297 1.1× 449 1.9× 162 1.1× 104 0.8× 46 0.5× 27 912
P Segal Israel 17 351 1.3× 245 1.0× 211 1.4× 37 0.3× 30 0.3× 33 908
R A Hegele Canada 12 317 1.2× 306 1.3× 159 1.1× 60 0.5× 67 0.7× 26 824
Sverre Skrede Norway 20 74 0.3× 232 1.0× 484 3.3× 108 0.9× 85 0.9× 50 1.1k
D S Fredrickson United States 7 429 1.6× 433 1.8× 138 0.9× 56 0.5× 32 0.3× 10 912
Donna G. Virgil United States 13 168 0.6× 188 0.8× 150 1.0× 40 0.3× 40 0.4× 17 488
J D Morrisett United States 13 316 1.2× 440 1.8× 154 1.0× 97 0.8× 50 0.5× 18 928
C B Marenah United Kingdom 17 167 0.6× 289 1.2× 123 0.8× 112 0.9× 51 0.5× 30 670
Claude L. Malmendier Belgium 18 380 1.4× 432 1.8× 303 2.0× 49 0.4× 52 0.5× 69 976

Countries citing papers authored by Olle Vikrot

Since Specialization
Citations

This map shows the geographic impact of Olle Vikrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olle Vikrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olle Vikrot more than expected).

Fields of papers citing papers by Olle Vikrot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olle Vikrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olle Vikrot. The network helps show where Olle Vikrot may publish in the future.

Co-authorship network of co-authors of Olle Vikrot

This figure shows the co-authorship network connecting the top 25 collaborators of Olle Vikrot. A scholar is included among the top collaborators of Olle Vikrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olle Vikrot. Olle Vikrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonsson, Bengt, Gunnar Öberg, Gösta Gahrton, et al.. (1992). Intensive Treatment in order to Minimize the Ph-Positive Clone in Chronic Myelogenic Leukemia. Leukemia & lymphoma. 7(sup1). 55–57. 15 indexed citations
2.
Rödjer, Stig, Olle Vikrot, Anders Wåhlin, & Jan Westin. (1990). Effect of interferon alpha‐2b in advanced multiple myeloma. Journal of Internal Medicine. 227(1). 45–48. 4 indexed citations
3.
Flodin, Ulf, et al.. (1981). A case-referent study on acute myeloid leukemia, background radiation and exposure to solvents and other agents. Scandinavian Journal of Work Environment & Health. 7(3). 169–178. 32 indexed citations
4.
Wallentin, Lars, Ragnar Berlin, & Olle Vikrot. (1977). Studies on Plasma Lipid and Phospholipid Composition in Pernicious Anemia before and after Specific Treatment. Acta Medica Scandinavica. 201(1-6). 161–165. 1 indexed citations
5.
Wallentin, Lars & Olle Vikrot. (1975). Lecithin:Cholesterol Acyl Transfer in Plasma of Normal Persons in Relation to Lipid and Lipoprotein Concentration. Scandinavian Journal of Clinical and Laboratory Investigation. 35(7). 669–676. 50 indexed citations
6.
Norrby, Klas & Olle Vikrot. (1975). Hypercalcaemia in Chronic Lymphatic Leukaemia. Scandinavian Journal of Haematology. 15(2). 132–138. 10 indexed citations
7.
Vikrot, Olle, et al.. (1971). INFLUENCE OF NICOTINIC ACID ON INDIVIDUAL PLASMA PHOSPHOLIPIDS IN HYPERCHOLESTEROLEMIC SUBJECTS. Acta Medica Scandinavica. 190(1-6). 133–136. 1 indexed citations
8.
Vikrot, Olle, et al.. (1971). INDIVIDUAL PLASMA PHOSPHOLIPIDS IN HYPERCHOLESTEROLEMIA. Acta Medica Scandinavica. 189(1-6). 93–96. 3 indexed citations
9.
Larsson‐Cohn, Ulf, et al.. (1970). EFFECTS OF COMBINED AND LOW-DOSE GESTAGEN ORAL CONTRACEPTIVES ON PLASMA LIPIDS; INCLUDING INDIVIDUAL PHOSPHOLIPIDS. European Journal of Endocrinology. 63(4). 717–735. 50 indexed citations
10.
Berlin, Ragnar, et al.. (1969). INCREASED LECITHINASE ACTIVITY AFTER HEPARIN ADMINISTRATION. Acta Medica Scandinavica. 185(1-6). 433–437. 11 indexed citations
11.
Berlin, Ragnar, et al.. (1969). ACUTE MYOCARDIAL INFARCTION AND PLASMA PHOSPHOLIPID LEVELS. Acta Medica Scandinavica. 185(1-6). 439–442. 15 indexed citations
12.
Berlin, Ragnar, et al.. (1969). LIPID CHANGES AFTER INCUBATION OF NORMAL PLASMA. Acta Medica Scandinavica. 185(1-6). 427–431. 14 indexed citations
13.
Svanborg, Alvar, et al.. (1967). Plasmalogens in Human Plasma During Pregnancy: A Study of Healthy Non‐pregnant and Pregnant Women. Acta Medica Scandinavica. 181(2). 147–151. 2 indexed citations
14.
Svanborg, Alvar & Olle Vikrot. (1967). Plasma Lipids in Recurrent Jaundice of Pregnancy. Acta Medica Scandinavica. 181(1). 83–87. 7 indexed citations
15.
Svanborg, Alvar & Olle Vikrot. (1966). The Effect of Estradiol and Progesterone on Plasma Lipids in Oophorectomized Women. Acta Medica Scandinavica. 179(5). 615–622. 43 indexed citations
16.
Brody, Sam, Ann‐Marie Hôgdahl, Ola Nilsson, Alvar Svanborg, & Olle Vikrot. (1966). The Effect of Some Ovulation Inhibitors on the Lipid Metabolism. Acta Medica Scandinavica. 179(4). 501–504. 27 indexed citations
17.
Vikrot, Olle, et al.. (1966). Plasma Phospholipid Levels and Distribution in Human Maternal Blood and in Blood from the Umbilical Cord. Acta Medica Scandinavica. 179(1). 1–4. 38 indexed citations
18.
Vikrot, Olle. (1965). Individual plasma phospholipids with special reference to the changes in pregnancy.. PubMed. 435. 1–23. 14 indexed citations
19.
Hôgdahl, Ann‐Marie & Olle Vikrot. (1965). Individual Plasma Phospholipids in Healthy Young Women. Acta Medica Scandinavica. 178(5). 637–642. 13 indexed citations
20.
Svanborg, Alvar & Olle Vikrot. (1965). Plasma Lipids during the First Week after Delivery. Acta Medica Scandinavica. 178(5). 631–636. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026